From Marginal to Central: Marginal Zone-like B Cells as Critical Targets in Cladribine-Treated Multiple Sclerosis - Quiz - MDSpire

Transitioning from Marginal to Central: The Role of Marginal Zone-like B Cells as Key Targets in Multiple Sclerosis Patients Treated with Cladribine

  • By

  • Marta Pirronello

  • Mario Picozza

  • Gisella Guerrera

  • Silvia Corbisiero

  • Andrea Misiti

  • Roberta C. Placido

  • Alice Verdiani

  • Lorenzo de Marco

  • Manolo Sambucci

  • Elena Olivieri

  • Daniela F. Angelini

  • Esmeralda Quartuccio

  • Luca Prosperini

  • Carla Tortorella

  • Maria C. Buscarinu

  • Valeria Zancan

  • Francesca de Masi

  • Marco Salvetti

  • Claudio Gasperini

  • Giovanna Borsellino

  • Luca Battistini

  • June 18, 2026

Share

Original Source(s)

From Marginal to Central: Marginal Zone-like B Cells as Critical Targets in Cladribine-Treated Multiple Sclerosis

  • by Marta Pirronello, Mario Picozza, Gisella Guerrera, Silvia Corbisiero, Andrea Misiti, Roberta C. Placido, Alice Verdiani, Lorenzo de Marco, Manolo Sambucci, Elena Olivieri, Daniela F. Angelini, Esmeralda Quartuccio, Luca Prosperini, Carla Tortorella, Maria C. Buscarinu, Valeria Zancan, Francesca de Masi, Marco Salvetti, Claudio Gasperini, Giovanna Borsellino, Luca Battistini

  • June 18, 2026

Related Content

Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes

In Memoriam: J. Richard Baringer, MD (1935–2025)

Case Report: Overlapping multiple sclerosis and neuropsychiatric systemic lupus erythematosus with positive MOG-IgG: a case initially misdiagnosed as depression